Literature DB >> 4595299

Use of bacteriophage phi chi 174 replicative from progeny DNA as templates for transcription.

N Truffaut, R L Sinsheimer.   

Abstract

The synthesis of phiX174-specific RNA has been studied in infected cells in which the thymine of the viral (+) strand of the parental RF(*), of the complementary (-) strand of the parental RF, or of both strands of the progeny RF molecules has been replaced with 5-bromouracil (5 BU). By irradiation of such cells with UV light at a wavelength of 313 nm it was possible to affect, specifically, the 5 BU-labeled strands. When the progeny RF molecules contain thymine, irradiation has no effect upon the synthesis of viral-specific RNA, regardless of 5 BU substitution in either strand of parental RF. If, however, progeny RF is labeled with 5 BU, irradiation produces a major decrease of viral RNA synthesis. It is concluded that many progeny RF molecules can serve as templates for transcription at late times of infection. Irradiation, prior to RF replication, of cells in which, particularly, the complementary strand of RF contains 5 BU, appears to decrease the ability of the parental RF to replicate.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4595299      PMCID: PMC355380     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  RESTRICTION OF IN VIVO GENETIC TRANSCRIPTION TO ONE OF THE COMPLEMENTARY STRANDS OF DNA.

Authors:  M HAYASHI; M N HAYASHI; S SPIEGELMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-10       Impact factor: 11.205

2.  Genetic Expression in Heterozygous Replicative Form Molecules of phiX174.

Authors:  V Merriam; L B Dumas; R L Sinsheimer
Journal:  J Virol       Date:  1971-05       Impact factor: 5.103

3.  The influence of 5-bromodeoxyuridine substitution on UV sensitivity, host-cell reactivation, and photoreactivation in T1 and P22H5.

Authors:  W SAUERBIER
Journal:  Virology       Date:  1961-12       Impact factor: 3.616

4.  Mechanism of transcription of bacteriophage S13. I. Dependence of messengerRNA synthesis on amount and configuration of DNA.

Authors:  A Puga; I Tessman
Journal:  J Mol Biol       Date:  1973-03-25       Impact factor: 5.469

5.  Characterization and synthesis of phi X174 proteins in ultraviolet-irradiated and unirradiated cells.

Authors:  G N Godson
Journal:  J Mol Biol       Date:  1971-05-14       Impact factor: 5.469

6.  Studies on phiX174 proteins. I. Phage-specific proteins synthesized after infection of Escherichia coli.

Authors:  A B Burgess; D T Denhardt
Journal:  J Mol Biol       Date:  1969-09-28       Impact factor: 5.469

7.  Electrophoretic characterization of phiX174-specific proteins.

Authors:  D H Gelfand; M Hayashi
Journal:  J Mol Biol       Date:  1969-09-28       Impact factor: 5.469

8.  The process of infection with bacteriophage phiX174. XXVI. Transfer of the parental DNA of bacteriophage phiX174 into progeny bacteriophage particles.

Authors:  R Knippers; W O Salivar; J E Newbold; R L Sinsheimer
Journal:  J Mol Biol       Date:  1969-02-14       Impact factor: 5.469

9.  The process of infection with bacteriophage phi-X174. IV. Replication of the viral DNA in a synchronized infection.

Authors:  D T Denhardt; R L Sinsheimer
Journal:  J Mol Biol       Date:  1965-07       Impact factor: 5.469

10.  Participation of a DNA-RNA hybrid complex in in vivo genetic transcription.

Authors:  M N Hayashi; M Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1966-03       Impact factor: 11.205

View more
  2 in total

1.  Process of infection with bacteriophage phiX174. XXXVII. RNA metabolism in phiX174-infected cells.

Authors:  J B Clements; R L Sinsheimer
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Electrophoretic characterization of intracellular forms of bacteriophage phi X174 DNA: identification of novel intermediate of altered superhelix density.

Authors:  P H Johnson; M J Miller; E Wild; S V Kelly; L I Grossman
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.